Trigger inducible tertiary lymphoid structure formation using covalent organic frameworks for cancer immunotherapy.
Zhang L, Zhang B, Zhang MJ, Li W, Li H, Jiao Y, Yang QC, Wang S, Liu YT, Song A, Feng HT, Sun J, Kwok RTK, Lam JWY, Tang BZ, Sun ZJ.
Zhang L, et al. Among authors: feng ht.
Nat Commun. 2025 Jan 2;16(1):44. doi: 10.1038/s41467-024-55430-4.
Nat Commun. 2025.
PMID: 39747845